Prosecution Insights
Last updated: October 02, 2026
Application No. 18/780,203

PROSTHETIC HEART VALVE HAVING FRAME WITH VARYING STRUT LENGTHS

Non-Final OA §103§112
Filed
Jul 22, 2024
Priority
Jan 24, 2022 — provisional 63/302,310 +1 more
Examiner
DUDDEN, TERESA MARIE
Art Unit
Tech Center
Assignee
Edwards Lifesciences Corporation
OA Round
1 (Non-Final)
48%
Grant Probability
Moderate
1-2
OA Rounds
1y 7m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
13 granted / 27 resolved
-11.9% vs TC avg
Strong +45% interview lift
Without
With
+45.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
49 currently pending
Career history
75
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
52.3%
+12.3% vs TC avg
§102
20.2%
-19.8% vs TC avg
§112
24.0%
-16.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 27 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 10 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 10 recites “a first axially extending post” in line 2. It is unclear if this is the same first axially extending post recited in claim 9 line 2 or a separate and distinct first axially extending post. The Examiner understands these to be the same post and recommends amending claim 10 to read “the first axially extending post”. Claim 10 recites “a second axially extending post” in lines 3-4. It is unclear if this is the same second axially extending post recited in claim 9 lines 3-4 or a separate and distinct second axially extending post. The Examiner understands these to be the same post and recommends amending claim 10 to read “the second axially extending post”. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Cartledge (US 2013/0166017 A1) in view of Pintor (US 2010/0161036 A1). Regarding claim 1, Cartledge teaches a prosthetic heart valve (13500, valve assembly fig. 135) comprising: a radially expandable and compressible frame (figs. 135 & 137) comprising: a plurality of groups of four outer struts and two axial struts forming a plurality of hexagonal outer cells arranged side-by-side in a circumferential direction of the frame (see annotated fig. 135, below), and a plurality of groups of four inner struts forming a plurality of diamond-shaped inner cells (see annotated fig. 135, below), wherein each inner cell is located within a respective outer cell (fig. 135), a valvular structure disposed within the frame (13540, valve, fig. 135)and configured to regulate the flow of blood through the frame in one direction. The phrase “a valvular structure and configured to regulate the flow of blood through the frame in one direction” is a functional recitation (see MPEP 2114.II). The prior art is not required to explicitly disclose the recited function, but merely have the capability of performing [or being manipulated to] the recited function in order to meet the claim requirements. In this case, the valve is considered to be capable of regulating the flow of blood through the frame in one direction. PNG media_image1.png 369 409 media_image1.png Greyscale Cartledge fails to teach the outer struts are shorter than the inner struts. However, Pintor teaches a stent that includes outer struts that are shorter than the inner struts (see annotated fig. 5A, below). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filling date of the claimed invention to have modified the length of the struts of Cartledge to include the outer struts are shorter than the inner struts as taught by Pintor since it is a simple substitution of one known element for another to obtain predictable results, which courts have recognized supports a conclusion of obviousness (see MPEP 2143). Further, courts have found support for a conclusion of obviousness where the modification merely involves choosing from a finite number of identified, predictable solutions, with a reasonable expectation of success (see MPEP 2143). In the instant case the outer struts are either larger, smaller or the same as the inner struts. PNG media_image2.png 216 260 media_image2.png Greyscale Regarding claim 2, Cartledge further teaches wherein the inner struts have a first uniform length (fig. 135). Regarding claim 3, Cartledge as modified by Pintor discloses the invention substantially as claimed and as discussed above with respect to claim 1, and additionally teaches wherein the outer struts have a second uniform length less than the first uniform length (fig. 135, Cartledge). Regarding claim 4, Cartledge further teaches the outer struts are curved (fig. 176). Regarding claim 5, Cartledge further teaches the frame comprises an inflow end (see annotated fig. 135, below) and an outflow end (see annotated fig. 135, below), each outer cell comprises an inflow apex disposed towards the inflow end (see annotated fig. 135, below) and an outflow apex disposed towards the outflow end (see annotated fig. 135, below), and for each outer cell, a first pair of two of the outer struts are connected to the inflow apex (see annotated fig. 135, below), and a second pair of two of the outer struts are connected to the outflow apex (see annotated fig. 135, below). PNG media_image3.png 398 567 media_image3.png Greyscale Regarding claim 6, Cartledge further teaches for each outer cell, each outer strut of the first pair comprises a curved portion adjacent the inflow apex (see annotated fig. 176, below) and each outer strut of the second pair comprises a curved portion adjacent the outflow apex (see annotated fig. 176, below. PNG media_image4.png 423 339 media_image4.png Greyscale Regarding claim 7, Cartledge further teaches each inner cell comprises an inflow apex disposed towards the inflow end (see annotated fig. 135, below) and an outflow apex disposed towards the outflow end (see annotated fig. 135, below), and for each inner cell, a first pair of two of the inner struts are connected to the inflow apex of the inner cell (see annotated fig. 135, below), and a second pair of two of the inner struts are connected to the outflow apex of the inner cell (see annotated fig. 135, below). PNG media_image5.png 398 703 media_image5.png Greyscale Regarding claim 8, Cartledge further teaches the frame comprises a plurality of pairs of first and second axially extending posts (see annotated, fig. 137, below), wherein the first and second posts of each pair are axially spaced from each other (fig. 137), and wherein each pair of first and second posts is positioned circumferentially between two of the axial struts (fig. 137). PNG media_image6.png 423 348 media_image6.png Greyscale Regarding claim 9, Cartledge further teaches for each inner cell, the inner struts of the first pair of inner struts are connected to a first axially extending post of a pair of first and second posts (fig. 135), and the inner struts of the second pair of inner struts are connected to a second axially extending post of the pair of first and second posts (fig. 135). Regarding claim 10, Cartledge further teaches for each outer cell, the outer struts of the first pair of outer struts are connected to a first axially extending post of a pair of first and second posts (fig. 135), and the outer struts of the second pair of outer struts are connected to a second axially extending post of the pair of first and second posts (fig. 135). Regarding claim 11, Cartledge further teaches a plurality of actuator members (13520, jacks, fig. 135), each extending through a pair of first and second axially extending posts (fig. 135). Regarding claim 12, Cartledge teaches a prosthetic heart valve (13500, valve assembly fig. 135) comprising: a radially expandable and compressible frame (figs. 135 &137) comprising: a plurality of circumferentially spaced axial struts (see annotated fig. 135, below); a plurality of pairs of axial posts, wherein each pair of axial posts is positioned circumferentially between two axial struts (see annotated fig. 135, below); a plurality of rows of angled struts, including at least a first row, a second row downstream of the first row, a third row downstream of the second row, and a fourth row downstream of the third row (see annotated fig. 135, below), wherein each angled strut is connected at one end to an axial strut and at another end to an axial post (fig. 135); and a valvular structure disposed within the frame (13540, valve, fig. 135)and configured to regulate the flow of blood through the frame in one direction. The phrase “a valvular structure and configured to regulate the flow of blood through the frame in one direction” is a functional recitation (see MPEP 2114.II). The prior art is not required to explicitly disclose the recited function, but merely have the capability of performing [or being manipulated to] the recited function in order to meet the claim requirements. In this case, the valve is considered to be capable of regulating the flow of blood through the frame in one direction. PNG media_image7.png 387 542 media_image7.png Greyscale Cartledge fails to teach the struts of the first and fourth rows are shorter than the struts of the second and third rows. However, Pintor teaches a stent that includes outer struts that are shorter than the inner struts (see annotated fig. 5A, below). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filling date of the claimed invention to have modified the length of the struts of Cartledge to include the outer struts are shorter than the inner struts as taught by Pintor since it is a simple substitution of one known element for another to obtain predictable results, which courts have recognized supports a conclusion of obviousness (see MPEP 2143). Further, courts have found support for a conclusion of obviousness where the modification merely involves choosing from a finite number of identified, predictable solutions, with a reasonable expectation of success (see MPEP 2143). In the instant case the outer struts are either larger, smaller or the same as the inner struts. PNG media_image2.png 216 260 media_image2.png Greyscale Regarding claim 13, Cartledge further teaches the valvular structure comprises a plurality of commissures (¶ [0371]), wherein each of the commissures is connected to one of the axial struts (fig. 135). Regarding claim 14, Cartledge further teaches the second row of angled struts and the third row of angled struts form a plurality of diamond-shaped cells arranged in a circumferentially extending row of cells (see annotated fig. 135, below). PNG media_image8.png 387 542 media_image8.png Greyscale Regarding claim 15, Cartledge further teaches the first row of angled struts, the fourth row of angled struts, and the axial struts form a plurality of hexagon-shaped cells (see annotated fig. 135, below) arranged in a circumferentially extending row of cells, wherein each diamond-shaped cell is disposed within a respective hexagon-shaped cell (fig. 135). PNG media_image9.png 387 542 media_image9.png Greyscale Regarding claim 16, Cartledge teaches a prosthetic heart valve (13500, valve assembly fig. 135) comprising: a radially expandable and compressible frame (figs. 135 & 137) comprising a plurality of cell columns arranged in a circumferentially extending row of cell columns (see annotated fig. 135, below), wherein each cell column comprises an outer cell (see annotated fig. 135, below) and an inner cell (see annotated fig. 135, below) disposed within the outer cell (fig. 135), wherein each inner cell comprises four angled inner struts (fig. 135) and each outer cell comprises four angled outer struts (fig. 135) and a valvular structure disposed within the frame (13540, valve, fig. 135)and configured to regulate the flow of blood through the frame in one direction. The phrase “a valvular structure and configured to regulate the flow of blood through the frame in one direction” is a functional recitation (see MPEP 2114.II). The prior art is not required to explicitly disclose the recited function, but merely have the capability of performing [or being manipulated to] the recited function in order to meet the claim requirements. In this case, the valve is considered to be capable of regulating the flow of blood through the frame in one direction. PNG media_image10.png 468 533 media_image10.png Greyscale Cartledge fails to teach the outer struts are shorter than the inner struts. However, Pintor teaches a stent that includes outer struts that are shorter than the inner struts (figs. 5A-5B).Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filling date of the claimed invention to have modified the length of the struts of Cartledge to include the outer struts are shorter than the inner struts as taught by Pintor since it is a simple substitution of one known element for another to obtain predictable results, which courts have recognized supports a conclusion of obviousness (see MPEP 2143). Further, courts have found support for a conclusion of obviousness where the modification merely involves choosing from a finite number of identified, predictable solutions, with a reasonable expectation of success (see MPEP 2143). In the instant case the outer struts are either larger, smaller or the same as the inner struts. Regarding claim 17, Cartledge further teaches the frame comprises a plurality of circumferentially spaced axial struts (see annotated fig. 135, below) and a plurality of pairs of axial posts (see annotated fig. 135, below), wherein each pair of axial posts is positioned circumferentially between two axial struts (fig. 135); and each angled outer strut is connected at one end to an axial strut and at another end to an axial post (fig. 135). PNG media_image11.png 468 638 media_image11.png Greyscale Regarding claim 18, Cartledge further teaches each angled inner strut is connected at one end to an axial strut and at another end to an axial post (fig. 135). Regarding claim 19, Cartledge further teaches each cell column extends an entire length of the frame from an inlet end of the frame to an outlet end of the frame (fig. 135). Regarding claim 20, Cartledge further teaches the frame is cylindrical (fig. 135). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TERESA M DUDDEN whose telephone number is (571)272-0435. The examiner can normally be reached Monday - Friday 7:30 am - 5:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JERRAH C EDWARDS can be reached at 408-918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /T.M.D./Examiner, Art Unit 3774 /YASHITA SHARMA/Primary Patent Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Jul 22, 2024
Application Filed
Aug 20, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12714553
INTRAOCULAR LENS WITH FOCAL PERFORMANCE TAILORED TO PUPIL SIZE DEPLOYING REFRACTIVE POWER MODIFICATION ALONG SPIRAL TRACKS
4y 3m to grant Granted Aug 25, 2026
Patent 12653673
ANNULAR AUGMENTATION DEVICE FOR CARDIAC VALVE REPAIR
5y 3m to grant Granted Jun 16, 2026
Patent 12648854
ARTIFICIAL JOINT STEM
3y 6m to grant Granted Jun 09, 2026
Patent 12594167
HIP IMPLANT SYSTEM
3y 4m to grant Granted Apr 07, 2026
Patent 12589015
STENT DELIVERY SYSTEM, ENDOSCOPE SYSTEM, AND STENT INDWELLING METHOD
3y 7m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
48%
Grant Probability
93%
With Interview (+45.2%)
3y 10m (~1y 7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 27 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month